Established regenerative medicine and wellness healthcare business operating four clinics across Oahu, Maui and Hawaii Island. Founded in 2021, the company generated $4,601,132 in revenue and $1,465,304 in normalized EBITDA in 2025, representing an approximately 31.8% normalized EBITDA margin.
The business provides elective, primarily self-pay healthcare services covering musculoskeletal, neurological, regenerative and wellness care. Services include joint and nerve treatment programs, PRP, A2M, BMAC, peptide therapy and selected hair and skin restoration treatments.
Revenue has grown from approximately $2.02 million in 2023 to $4.12 million in 2024 and $4.60 million in 2025.
An experienced Hawaii-based Clinic Director oversees day-to-day operations, supported by licensed healthcare providers, medical assistants, front-office personnel and dedicated marketing staff. The majority owner has limited involvement in routine daily operations.
The business benefits from an established patient-acquisition platform incorporating digital marketing, television, radio, webinars, seminars, events and professional referrals.
The asking price includes furniture, fixtures and equipment valued at $50,500 and inventory valued at $32,000. Transferable business, brand and digital assets are also contemplated as part of the transaction, subject to final sale terms.
